Valente Nancy
- SEC CIK
- 0001891344
No open-market purchases or sales filed in the past year.
Current role at each company
- XNCR Xencor IncEVP, Chief Development Officeras of May 6, 2025
- MYOV Myovant Sciences Ltd.Directoras of Mar 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Valente Nancy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XNCR Xencor Inc
EVP, Chief Development Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2025 (view filing) | May 2 | 4 days | Valente NancyEVP, Chief Development Officer | SSale | −4.62K | $11.03 | −$50.9K | −8.6%49.2K after | |
| Mar 11, 2025 (view filing) | Mar 10 | 1 day | Valente NancyEVP, Chief Development Officer | SSale | −2.56K | $13.60 | −$34.9K | −4.6%53.8K after | |
| May 3, 2024 (view filing) | May 2 | 1 day | Valente NancyEVP, Chief Development Officer | SSale | −4.75K | $23.58 | −$111.9K | −7.9%55.1K after |